These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4807078)

  • 1. [Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):379-83. PubMed ID: 4807078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of anginine on the state of the stomach and pancreas in diabetes mellitus].
    Semichastnova AG; Golubiatnikova GA; Permiakov NK; Titova GP; Bokaneva IA
    Sov Med; 1975 Oct; (10):36-42. PubMed ID: 1209326
    [No Abstract]   [Full Text] [Related]  

  • 3. [The efficacy of pyridonolcarbamate in diabetic angiopathy].
    Furitano G; Cajozzo A; Notarbartolo A
    Minerva Med; 1975 Dec; 66(85):4599-602. PubMed ID: 1196545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
    Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma kinin system indices in diabetes mellitus patients before and after treatment with prodectin].
    Spesivtseva VG; Men'shikov VV; Beliakov NV; Mamaeva GG; Stepanova NI
    Probl Endokrinol (Mosk); 1978; 24(6):19-22. PubMed ID: 724671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 7. Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report.
    Girolami A; Peruffo R; Emanueli A
    Arzneimittelforschung; 1977; 27(6):1202. PubMed ID: 578441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA; Caputo G
    Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
    Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
    Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rheographic normalization in prediabetic subjects treated with pyridinolcarbamate].
    Furitano G; Paterna S; Di Pasquale P
    Minerva Med; 1978 May; 69(24):1655-9. PubMed ID: 662168
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridinolcarbamate in the long-term treatment of ischaemic heart disease.
    Gulyás A; Szám I
    Ther Hung; 1976; 24(2):63-6. PubMed ID: 982341
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
    Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
    Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
    Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
    Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
    [No Abstract]   [Full Text] [Related]  

  • 18. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI; Tolstova LG
    Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
    [No Abstract]   [Full Text] [Related]  

  • 19. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
    Hunyi L
    Ther Hung; 1976; 24(2):67-71. PubMed ID: 982342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.